The new, four-year Devices, Diagnostics, and Drugs to Address Women’s Needs Product Development Partnership (D3AWN PDP) is tapping into PATH’s deep PDP expertise to develop and introduce a portfolio of devices, diagnostics, and drugs to prevent or manage preeclampsia/eclampsia (PE/E) and PPH. The D3AWN PDP is advancing affordable, accessible, safe, and effective tools for sub-Saharan communities. Solutions include:
Publication date: June 2019
The LifeAssay Diagnostics Test-it™ urinary dipstick test is accurate, easy to use, and inexpensive, making it appropriate for use during routine antenatal care services in low-resource areas.
The RELI Delivery System combines the low cost and simplicity of non-electric disposable pumps with the functionality and accuracy of electronic devices, without the need for proprietary consumables.
The Ellavi UBT is a preassembled, ready to use low-cost medical device (CE Mark) with a unique mechanism of action and several advantages over UBT products on the market and existing stop-gap measures.
Sublingual oxytocin in heat-stable fast-dissolving tablets offers a flexible needle-free presentation that can be available in multiple packaging options, making it easy to administer for the prevention of PPH.